5Y Capital

5Y Capital is a private equity and venture capital firm based in Xuhui, Shanghai, China, founded in 2008 by Ken Shi and Richard Liu. The firm specializes in early-stage venture investments and is dedicated to supporting entrepreneurs in building their companies. With over USD 5 billion in capital under management, 5Y Capital attracts global investors, including sovereign wealth funds, endowments, foundations, family offices, and funds of funds. Formerly known as Morningside Venture Capital, 5Y Capital aims to foster innovation and growth in the entrepreneurial ecosystem.

Peter Chen

Managing Director

Yu Cheng

Partner

Victor Jin

Managing Director

Ted Xutian Jing

Managing Director

Levi Liu

Partner

Jerry Tong

Senior Investment Associate

Tony Yeung

Managing Director

Zeng Ying

Partner

Cloris You

Managing Director

Elwin Yuan

Partner

Yuan Ye

Partner

Fisher Zhang

Partner

Fei Zhang

Partner

Bo Zhang

Managing Director

He Kaiyan

investor

Past deals in New England

Hopewell Therapeutics

Seed Round in 2023
Hopewell Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, that specializes in developing synthetic lipid-based drug delivery systems. Founded in 2018, the company focuses on creating biodegradable lipid nanoparticles designed for the delivery of nucleic acids in gene therapy and gene editing applications. Their innovative technology aims to enhance the efficacy of genomic medicines, providing healthcare professionals with improved tools for immunotherapy and related therapies. Through its advancements in drug delivery, Hopewell Therapeutics seeks to facilitate the safe and effective administration of cutting-edge treatments to patients.

XYZ Robotics

Series B in 2022
XYZ Robotics, established in 2018, specializes in automating logistics and manufacturing processes. Headquartered in Shanghai with an additional office in Boston, the company leverages 3D AI, robotic manipulation algorithms, and tooling designs to streamline picking, sorting, and packing operations. Its innovative machine vision and robotic intelligence software platform enhances productivity across diverse industries, including automotive, pharmaceuticals, e-commerce, and retail. Typical applications range from robotic depalletizing to vision-guided assembly.

XtalPi Technology

Series D in 2021
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

XYZ Robotics

Series B in 2021
XYZ Robotics, established in 2018, specializes in automating logistics and manufacturing processes. Headquartered in Shanghai with an additional office in Boston, the company leverages 3D AI, robotic manipulation algorithms, and tooling designs to streamline picking, sorting, and packing operations. Its innovative machine vision and robotic intelligence software platform enhances productivity across diverse industries, including automotive, pharmaceuticals, e-commerce, and retail. Typical applications range from robotic depalletizing to vision-guided assembly.

Coin Metrics

Series B in 2021
Coin Metrics Inc. is a provider of blockchain and cryptocurrency data analytics, based in Cambridge, Massachusetts. Founded in 2017, the company specializes in delivering market and network data, analytics, and research to various industries and institutions involved in crypto-assets. Its offerings include the CM Network Data Pro, which provides comprehensive historical data on top cryptocurrency assets, and the CM Market Data Feed, which standardizes trade, candle, and order book data from multiple exchanges. Additionally, Coin Metrics offers CM Reference Rates, which present fixed asset pricing in U.S. dollars. By focusing on transparency and actionable data, Coin Metrics aims to empower individuals and organizations to make informed financial decisions related to cryptocurrencies.

Stavvy

Series A in 2021
Stavvy, Inc. is a financial technology company based in Boston, Massachusetts, that specializes in a digital mortgage vendor platform aimed at transforming the lending experience. Founded in 2018 and originally named Stavros Technologies, the company provides tools such as Stavvy Connect, which facilitates secure communication and access to vendor data for mortgage banking professionals during the underwriting and settlement processes. Additionally, Stavvy Notarize enables title agents, lawyers, and notaries to conduct virtual closings and meetings in real-time using web conference technology. By eliminating paper-based processes and enhancing communication, Stavvy aims to improve operational efficiency while minimizing risk for its users in the mortgage industry.

XtalPi Technology

Series C in 2020
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

XYZ Robotics

Series A in 2020
XYZ Robotics, established in 2018, specializes in automating logistics and manufacturing processes. Headquartered in Shanghai with an additional office in Boston, the company leverages 3D AI, robotic manipulation algorithms, and tooling designs to streamline picking, sorting, and packing operations. Its innovative machine vision and robotic intelligence software platform enhances productivity across diverse industries, including automotive, pharmaceuticals, e-commerce, and retail. Typical applications range from robotic depalletizing to vision-guided assembly.

XYZ Robotics

Series A in 2019
XYZ Robotics, established in 2018, specializes in automating logistics and manufacturing processes. Headquartered in Shanghai with an additional office in Boston, the company leverages 3D AI, robotic manipulation algorithms, and tooling designs to streamline picking, sorting, and packing operations. Its innovative machine vision and robotic intelligence software platform enhances productivity across diverse industries, including automotive, pharmaceuticals, e-commerce, and retail. Typical applications range from robotic depalletizing to vision-guided assembly.

XtalPi Technology

Series B in 2019
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

Freight Farms

Venture Round in 2017
Freight Farms, Inc. specializes in manufacturing innovative crop production units constructed from up-cycled shipping containers. Its flagship product, the Leafy Green Machine, is a pre-assembled hydroponic farm capable of producing commercial-scale yields of various crops, including herbs like mint and basil, as well as different types of lettuce and hearty greens such as kale and cabbage. Founded in 2010 and based in Boston, Massachusetts, Freight Farms aims to provide access to fresh and affordable food in regions where traditional farming is not feasible due to climate constraints. The company's technology promotes local food economies and sustainable food systems by enabling high-yield crop production regardless of environmental conditions. It serves a diverse clientele, including business owners, soil farmers, schools, municipalities, and non-profits across the United States, Canada, and Europe.

Clean Membranes

Series A in 2011
Clean Membranes, Inc. is a technology company based in Lexington, Massachusetts, specializing in the production of anti-fouling membranes for a wide range of water treatment applications. Established in 2008, the company offers innovative membranes designed for desalination of seawater and brackish water, purification of surface and well water, and treatment of municipal and industrial wastewater. Their proprietary smart copolymer membranes are hydrophilic and inherently resistant to fouling, which enhances water flow and improves filter performance and longevity. This technology is applicable in various sectors, including the pharmaceutical and food industries, oil and gas extraction, and municipal water systems. By combining high permeability with exceptional fouling resistance, Clean Membranes significantly reduces both manufacturing and operational costs compared to traditional membrane technologies, thereby promoting water conservation and enabling communities to access clean drinking water.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.